baber/WOPTO huggingface dataset:
Patent DK-1789358-T3 (DK)
Inventor: ROBINSON MICHAEL
IPC: B67D1/00
Filed: 2005-08-12
Granted: 2008-10-06
Abstract: A method of cleaning a beverage line (13) of a beverage dispense font, the font being of a type comprising condensation means (6) in thermal contact with the housing (4) through which, in use, a first cooling medium can flow, and further comprising a cooling loop (5) in thermal contact with the beverage line (3) through which, in use, a second cooling medium e.g water can flow. The method comprises the steps of: ```passing the first cooling medium through the condensation means to form condensation, frosting or ice on an exterior of the housing; ```at the same time passing the second cooling medium through the cooling line; ```at the same time passing a cleaning medium through the beverage line; ```whereby heat transfer between the cleaning medium and the first cooling medium is moderated by heat transfer between the second cooling medium and the cleaning medium. The condensation means (6) comprises a condensation plate (50) having pipework (88) thermally connected to a secondary cooling circuit comprising a cooler (90) for cooling a glycol cooling medium. The beverage font further comprises an illumination source mounted within the housing (4) for illuminating a panel or panels of the beverage font.
Patent DK-1783293-T3 (DK)
Inventor: KRECKEL THOMAS
IPC: E04C2/04
Filed: 2006-07-22
Granted: 2009-04-20
Abstract: Reinforced insulating body has insulating plate (3) on which fixing elements (6) are arranged unilaterally and perpendicular to planar side (4). A spacer (10) is provided on the ends of fixing element distant to the insulating plates. One fixing element is eliminated from the insulating plate on the reinforcing mat (9). An independent claim is also included for a prefabricated wall.
Patent DK-1752068-T3 (DK)
Inventor: HANSEN OLE JUUL
IPC: A47B23/00
Filed: 2006-08-11
Granted: 2009-05-18
Abstract: The transport and display tray (1) comprises a bottom (2) and circumferential side walls (3, 4, 5, 6). Two opposite side walls (3, 5) are provided with legs (8, 9) hinged on the side wall (3, 5) with a hinge axis extending at right angles to the side wall. There are abutments (10, 14) for the legs (8, 9), which are each pivotal between the abutments (10, 14) about the hinge axis between a leg position in which part of the leg extends down below the level of the bottom (2), and a handle position in which the leg extends above the level of the bottom to serve as a handle.
Patent DK-1979473-T3 (DK)
Inventor: TZORTZIS GEORGIOS
IPC: C12N9/10
Filed: 2007-01-23
Granted: 2011-05-23
Abstract: The present invention concerns a β-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum. The β-galactosidase is capable of converting lactose to a mixture of oligosaccharides which are β-linked and unexpectedly produces the α-linked disaccharide galactobiose. The mixture may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
Patent DK-1928109-T3 (DK)
Inventor: JONES ALED WYNNE
IPC: G10L19/14
Filed: 2001-11-30
Granted: 2012-08-27
Abstract: A cellular telephone operable to interact with an audio transmission, the apparatus comprising: a memory operable to store control data for causing the telecommunications apparatus to respond to the audio transmission; a receiver operable to receive an acoustic signal of the audio transmission and for converting the received acoustic signal into a corresponding electrical signal; a data processor, coupled to said acoustic signal receiver, and operable to process said electrical signal to recover data encoded within the audio of said audio transmission and to provide the recovered data to the telecommunications apparatus; and a responder operable to respond to the data recovered from the audio transmission in accordance with the stored control data after a delay defined by stored timing data to synchronize the response with the audio transmission.
Patent DK-2227078-T3 (DK)
Inventor: BEST DIETER
IPC: H01L23/40
Filed: 2009-03-04
Granted: 2012-02-20
Abstract: The clamping component has a housing frame (13) with a retaining chamber for cooling flange (7), where the retaining chamber encloses frame walls (14a,14b,15). The cooling flange is also provided for contacting a power semiconductor (9). A pressure component (17) is arranged between the frame wall and opposite power component or opposite cooling flange. The housing-frame and the respective pressure component are made of heat stable plastic, particularly polyamide. An independent claim is also included for an electronic housing for electric motor, which has a stator flange.
Patent DK-2325645-T3 (DK)
Inventor: HULETSKY ANN
IPC: G01N33/569
Filed: 2006-10-10
Granted: 2020-09-28
Abstract: ABSTRACT OF THE DISCLOSUREDescribed herein are novel SCCmec right extremity junction (MREJ) sequences for the detection and/or identification of methicillin-resistant Staphylococcus aureus (MRSA). Disclosed are methods and compositions based on DNA sequences for the specific detection of MREJ sequences designated types xi, xii, xiii, xiv, xv, xvi, xvii, xviii, xix, and xx for diagnostic purposes and/or epidemiological typing.
Patent DK-2643352-T3 (DK)
Inventor: BEMBRIDGE GARY PETER
IPC: C07K16/24
Filed: 2011-11-21
Granted: 2018-07-30
Abstract: The present invention concerns antigen binding proteins and fragments thereof specifically antibodies which bind to human OSM (hOSM) and which inhibits the binding of hOSM to the gp130 receptor but does not directly interact with site II residues, for use in the treatment or prophylaxis of a disease or disorder selected from inflammatory bowel disease (IBD) including Crohn's disease and ulcerative colitis (UC).. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
Patent DK-2998296-T3 (DK)
Inventor: PENG JIANBIAO
IPC: C07D471/04
Filed: 2014-04-29
Granted: 2018-05-22
Abstract: Cycloalkyl acid derivatives, a preparation method thereof, and a pharmaceutical application thereof are described. In particular, a cycloalkyl acid derivative represented by general formula (I) and a medical salt thereof, a preparation method thereof, and an application of the cycloalkyl acid derivative and the medical salt thereof as URAT1 inhibitors, and particularly as therapeutic agents for diseases related to an abnormal uric acid level are described, wherein definitions of substituent groups in general formula (I) are the same as the definitions in the specification.
Patent DK-0415456-T3 (DK)
Inventor: SUZUKI FUMIO
IPC: A61K31/52
Filed: 1990-08-31
Granted: 1996-07-29
Abstract: Novel xanthine compounds represented by the following formula: <CHEM> wherein each of R<1>, R<2> and R<3> independently represents a hydrogen atom or a lower alkyl group; each of X<1> and X<2> independently represents an oxygen or sulfur atom; <CHEM>  represents a single bond or a double bond; Y represents a single bond or an alkylene group, n represents 0 or 1, each of W<1> and W<2> independently represents a hydrogen atom, a lower alkyl or amino group, Z represents -CH2-, -O-, -S- or -NH-residues; provided that when Q is <CHEM> then R<1>, R<2> and R<3> are not simultaneously methyl; and physiologically acceptable salts thereof have a diuretic effect, a renal-protecting effect and/or a bronchodilatory effect. The compounds are useful as a diuretic, a renal-protecting agent and /or bronchodilator.
Patent DK-0413796-T3 (DK)
Inventor: POLLACH GUENTER
IPC: C13B10/00
Filed: 1990-03-09
Granted: 1995-02-27
Abstract: In a multistage process for optimal utilization of the substances contained in sugar beet, a new special raw sugar, white sugar and the storable by-products, molasses and dry pulp, are extracted. To this end, a first juice for the production of white sugar is first extracted from the sugar beet, a second juice for the production of the new special raw sugar is then extracted and finally a third juice, also for the production of white sugar, is extracted.
Patent DK-0479799-T3 (DK)
Inventor: ANTONIADES HARRY N
IPC: A61K38/30
Filed: 1990-04-10
Granted: 1997-08-25
Abstract: Healing an external wound or regenerating bone of a mammal by administering to the mammal a composition containing purified platelet-derived growth factor and purified insulin-like growth factor II.
Patent DK-0478654-T3 (DK)
Inventor: BLANK LUTZ CHRISTIAN
IPC: G01M11/00
Filed: 1990-06-22
Granted: 1994-03-14
Abstract: Apparatus and a method for increasing the optical measurement range in optical time domain reflectometers in which a fibre laser amplifier is used to amplify the optical time domain reflectometer pulses launched into a waveguide. This apparatus and method have particular usefulness for branched local networks. The signal returning to the optical time domain reflectometer is amplified as well as the outbound signal.
Patent DK-0493428-T3 (DK)
Inventor: MOHN FRANK
IPC: F04D/
Filed: 1990-09-18
Granted: 1995-12-18
Abstract: PCT No. PCT/GB90/01435 Sec. 371 Date May 8, 1992 Sec. 102(e) Date May 8, 1992 PCT Filed Sep. 18, 1990 PCT Pub. No. WO91/04417 PCT Pub. Date Apr. 4, 1991.A pump or compressor module for undersea use has a housing having a pump or compressor unit received therein. The pump or compressor unit has first and second impeller assemblies. The first and second impeller assemblies are driven in opposed directions about a common axis. The drive has first and second electric motors having respective drive shafts drivingly connected to the first and second impeller assemblies respectively. First and second motor casings contain the first and second motors respectively, the motor casings being within the housing. There is a seal compartment in each of the motor casings and a drive shaft seal within each of seal compartments. Barrier fluid is supplied to each of the seal compartments at a higher pressure than to the rest of the motor casing. The housing has end portions accommodating the first and a second electric motors respectively and a central portion between the end portions accommodating the impeller assemblies, and providing an inlet chamber communicating with a fluid inlet.
Patent DK-0479950-T3 (DK)
Inventor: PUHL LARRY CHARLES
IPC: H04W56/00
Filed: 1990-06-22
Granted: 1997-09-22
Abstract: In a Time Division Multiple Access (TDMA) cellular system, there is provided a mechanism for synchronization and equalization comprising: providing synchronization information (S/S) sufficiently removed from the start of a TDM slot so as to maintain the integrity of that synchronization information (S/S) at adjacent cells and providing that synchronization information (S/S) not so far removed from the start of the slot as to necessitate adaptive equalization of information preceding the synchronization information (S/S) for sufficiently reliable recovery. The equalization is further enhanced by providing, roughly midway between the synchronization information (S/S) and the end of the slot, additional information (CC) upon which equalization may retrain. Accordingly, equalizers perform retrospective, non-adaptive equalization of information preceding the synchronization information (S/S), perform adaptive equalization of information following that synchronization information (S/S), and retrain utilizing known bit-sequences elsewhere within the TDM slot; the additional information (CC) comprises known bit-sequences identifying cells.
Patent DK-0471217-T3 (DK)
Inventor: RATJEN WERNER
IPC: A23L33/28
Filed: 1991-07-24
Granted: 1998-04-27
Abstract: The composition consists of a two-part gelatin capsule in which there is a substance which increases in volume on release in the stomach, is non-toxic and has a low calorific value, and which can be broken down again within the digestive tract of the human body, for example compressed cellulose. This confers a feeling of repletion on the person taking it, owing to the enlargement in volume in the stomach, for a certain time, which facilitates weight reduction.
Patent DK-0470437-T3 (DK)
Inventor: HAGER JOERG
IPC: A61K9/127
Filed: 1991-07-24
Granted: 1995-12-27
Abstract: An aqueous liposome system which has, where appropriate, besides a non-toxic organic solvent at least one phospholipid is described. The liposome system moreover contains besides the at least one phospholipid furthermore at least one phospholipidic charge carrier.
Patent DK-0527889-T3 (DK)
Inventor: CHU DANIEL T
IPC: A61K31/435
Filed: 1991-05-01
Granted: 2000-12-18
Abstract: Novel compounds are disclosed having formula (I) as well as pharmaceutically acceptable salts, esters and amides thereof, wherein R<1> is selected from (a) loweralkyl, (b) loweralkenyl, (c) halo(loweralkyl), (d) loweralkoxy, (e) cycloalkyl of from 3 to 8 carbons, (f) phenyl, (g) halo, (h) cyano, (i) nitro, (j) bicycloalkyl, (k) loweralkynyl, (l) alkoxycarbonyl, (m) nitrogen-containing aromatic heterocycle and (n) a group of the formula -NR<7>R<8>; R<2> is selected from the group consisting of halogen, loweralkoxy, carbocyclic aryloxy or carbocyclic aryl(loweralkyl)oxy, loweralkyl, loweralkenyl, cycloalkyl of from 3 to 8 carbons, cycloalkenyl of from 4 to 8 carbons, carbocyclic aryl(loweralkyl), cycloalkyl(loweralkyl), phenyl, amino, (loweralkyl)amino, carbocyclic aryl(loweralkyl)amino, hydroxy-substituted (loweralkyl)amino, nitrogen-containing aromatic heterocycle, bicyclic nitrogen-containing heterocycle and nitrogen-containing heterocycle having formula (II), wherein x is 0 to 3; R<9> is selected from (a)-(CH2)m-, wherein m is 1, 2 or 3, and (b) -(CH2)nR<10>(CH2)p-, wherein R<10> is selected from S, O and N, n is 1 or 2, and p is 1 or 2; and Y is a non-hydrogen substituent independently selected from loweralkyl, halo(loweralkyl), loweralkoxy, hydroxy-substituted loweralkyl, hydroxy, amino(loweralkyl), halogen and a group having the formula -NR<11>R<12>; R<3> is hydrogen, halogen or loweralkoxy; R<4> is selected from the group consisting of hydrogen, loweralkyl, a pharmaceutically acceptable cation and a prodrug ester group; R<5> is selected from the group consisting of hydrogen, halogen, hydroxy, loweralkyl, halo(loweralkyl), loweralkoxy and a group having the formula -NR<13>R<14>; and A is N or CR<6>, wherein R<6> is selected from hydrogen, halogen, loweralkyl, halo(loweralkyl), hydroxy-substituted loweralkyl, loweralkoxy(loweralkyl), loweralkoxy and amino(loweralkyl) or, alternatively, R<1> and R<6>, taken together with the atoms to which they are attached, form a 6-membered saturated ring which may contain an oxygen or a sulfur atom and which may be substituted with loweralkyl; with the proviso that when R<5> is hydrogen and A is CH then either (a) R<1> is NR<7>R<8>, or (b) R<2> is a group having formula (III), wherein x is 1-3 and R<9> and Y are as defined above.
Patent DK-0510467-T3 (DK)
Inventor: TANDETZKI HANS
IPC: B61D3/18
Filed: 1992-04-11
Granted: 1995-05-08
Abstract: The invention relates to a railway freight wagon for transporting semi-trailers (2a,2b) of road vehicles and/or containers and interchangeable containers which can be lifted by crane, having at least one pocket (7) which is located at a lower position with respect to the outer side members (3) and a support block (11), which can be adjusted in the longitudinal direction of the wagon, for receiving the kingpin (10). In order also to be able to transport oversized semi-trailers (2b) with a width of 2.60 m and containers and interchangeable containers inside the predetermined loading gauge profile, the support block (11) for optionally receiving the kingpin (10) of a normal or of an oversized semi-trailer (2a,2b) is vertically adjustable between two limit positions. Two support elements (14d) by means of which the rear end of an oversized semi-trailer (2b) can be fixed are arranged on the outer side members (3) of the underframe, the axle suspension of the oversized semi-trailer (2b) which is equipped with an axle lifting mechanism being relieved of stress in the loading position. <IMAGE>
Patent DK-0518769-T3 (DK)
Inventor: HUGON PIERRE
IPC: C07C219/14
Filed: 1992-06-12
Granted: 1995-05-29
Abstract: New ethanolamine benzoate compounds, which can be used as medicaments and which correspond to the formula: <IMAGE> in which R is as defined in the description, in the racemic and enantiomeric forms. These new compounds and their physiologically tolerable salts can be used in therapeutics.
Patent DK-0599842-T3 (DK)
Inventor: KOSKAN LARRY P
IPC: C08G73/10
Filed: 1991-08-15
Granted: 1997-03-10
Abstract: A process for the manufacture of polyamino acids, particularly polyaspartic acid. A solid, particulate, amino acid is fluidized by agitation in a nitrogen atmosphere and heated to a temperature of at least 180 DEG  C. and maintained at that temperature for a sufficient amount of time to polymerize the amino acid and to drive off water from the heated bed. A degree of agitation sufficient to substantially fluidize the particles is provided and a particle size of no more than 150 microns is maintained throughout the process. The resultant anhydropolyamino acid is then hydrolyzed to a polyamino acid.
Patent DK-0533865-T3 (DK)
Inventor: TOLPA STANISLAW
IPC: A61K35/10
Filed: 1992-03-04
Granted: 1998-09-14
Abstract: The peat-derived bioactive product contains not more than 70%, preferably not more than 60% by weight of inorganic salts, especially of sodium chloride, based on dry solids. It is obtainable by a process wherein a highly concentrated aqueous solution of inorganic salts, especially of sodium chloride containing peat-derived bioactive ingredients is diluted with demineralized water and subjected to reverse osmosis in order to desalinate the solution, inorganic salts being removed, and wherein the resulting solution is concentrated and clarified, and, optionally, in at least one further step, sterilized and/or spray-dried. A pharmaceutical formulation containing a peat-derived bioactive product, in the form of a gel, is prepared by combining a sterile alcoholic herb extract with sterile glycerol, a sterile aqueous solution of previously powdered peat-derived bioactive product and a sterile menthol solution; the resulting mixture is gradually combined with colloidal silica to convert the liquid composition into gel form, the weight ratio of liquid mixture to silica preferably being from 90:10 to 94:6. A cosmetic preparation such as a gel, ointment, balm, shampoo, bath salt lotion etc. contains as active ingredient the instant peat-derived bioactive product in a quantity of 0.01-10% by weight, preferably 0.05-1% by weight, more preferably 0.05-0.1% by weight.
Patent DK-0564972-T3 (DK)
Inventor: BREIPOHL GERHARD DR
IPC: A61K38/08
Filed: 1993-03-31
Granted: 2000-01-24
Abstract: Peptides of the formula I  Z - P - A - B - C - E - F - K - (D)Q - G- M- F' - I (I),  in which   Z is optionally substituted (cyclo)alk(ano)yl(sulphonyl), (C1-C8)-alkoxycarbonyl, (hetero)ar(o)yl(sulphonyl), carbamoyl,   P is a direct linkage or a radical II  -NR<2>-(U)-CO- (II> in which   R<2> is H, methyl or a urethane protective group,   U is (cyclo)(aryl)alkylidene, (hetero)arylidene or (CHR<3>)n,   R<3> is hydrogen, (cyclo)alkyl, (hetero)aryl, or in which R<2> and R<3> form, together with the atoms carrying them, a ring system;   A is defined as P;   B is a basic amino acid in the L or D configuration,   C is a compound of the formula IIIa or IIIb  G'-G'-Gly (IIIa> G'-NH-(CH2)p-CO (IIIb> in which p is 2 to 8 and   G' are, independently of one another, a radical of the formula IV -NR<4>-CHR<5>-CO- (IV> in which R<4> and R<5> form, together with the atoms carrying them, a heterocyclic ring system; E is the residue of a neutral, acid or basic, aliphatic or alicyclic-aliphatic amino acid; F are, independently of one another, the radical of a neutral, acid or basic, aliphatic or aromatic amino acid, or a direct linkage; (D)Q is D-Tic, D-Phe, D-Dic, D-Thi or D-Nal, or a radical of the formula (V) <IMAGE> in which X is O, S or a direct linkage, and R is H, (cyclo)alkyl or aryl(alkyl),   G is defined as G' above or is a direct linkage; F' is defined as F, is a radical -NH-(CH2)q- with q = 2 to 8 or, if G is not a direct linkage, can be a direct linkage, and   I is -OH, -NH2 or NHC2H5; K is the radical -NH-(CH2)x-CO- with x = 1-4 or is a direct linkage, and   M is defined as F  and their physiologically tolerated salts are described. They have excellent bradykinin-antagonistic action. They are obtained by reacting a fragment with a C-terminal free carboxyl group or its activated derivative with an appropriate fragment with an N-terminal free amino group, or by assembling the peptide stepwise, eliminating one or more protective groups temporarily introduced where appropriate to protect other functionalities in the compound obtained in this way, and converting the compounds of the formula I obtained in this way where appropriate into their physiologically tolerated salt.
Patent DK-0555178-T3 (DK)
Inventor: MAEDER ROLAND
IPC: A43B17/14
Filed: 1993-01-22
Granted: 1997-12-15
Abstract: The article comprises a plane basic body (5) which is intended for application to a plane surface (17). The application surface (21) of the flexible article is provided with islands (25) made of an adhesive agent or adhesive medium (25). The adhesive agent (25) is made of a material which remains adhesive virtually permanently even after setting. In at least one of the surfaces (2 or 3) of the basic body (5), cutouts (6) are made, which form patterns in the surface of the basic body (5). The islands (25) are situated between the cutouts (6). When this article is an insole, it virtually does not slide in the shoe. <IMAGE>
Patent DK-0600070-T3 (DK)
Inventor: MANLEY BARRY W
IPC: H01J37/34
Filed: 1993-05-25
Granted: 1999-05-10
Abstract: A sputtering magnet assembly includes a plate-shaped pole piece made from a magnetically permeable material and a central magnet positioned substantially at the center of the pole piece and oriented so that its north-south magnetic orientation is substantially perpendicular to the plate shaped pole piece. A plurality of outer magnets are positioned around the central magnet, each of which has its north-south magnetic orientation also perpendicular to the pole piece, but opposite of the orientation of the central magnet. A plurality of primary inner magnets are arranged around the central magnet, between the central magnet and the outer magnets, each of which primary inner magnets has its north-south magnetic orientation parallel to the base pole piece and perpendicular to the magnetic orientations of the central magnet and the outer magnets. The resulting sputtering magnet assembly produces a magnetic field having magnetic flux lines that define a sputtering region adjacent the front surface of the target and within the target body. The magnetic flux lines form an upper magnetic lobe, a lower magnetic lobe, an inner magnetic lobe, and an outer magnetic lobe, all of which are located substantially within the sputtering region. Further, the strengths and orientations of the magnetic lobes are such that a null point exists between the upper, lower, inner, and outer magnetic lobes.
Patent DK-0658347-T3 (DK)
Inventor: GLINTENKAMP LUETA ANN
IPC: A61K9/08
Filed: 1994-11-24
Granted: 2003-11-17
Abstract: A method of preparing an injectable pharmaceutical or veterinary composition which comprises either diclofenac or a salt thereof and 2-hydroxypropyl beta-cyclodextrin, or an inclusion complex of diclofenac or a salt thereof and 2-hydroxypropyl beta-cyclodextrin, includes the step of dissolving either the diclofenac or salt thereof and the 2-hydroxypropyl beta-cyclodextrin, or the inclusion complex, in water to form a solution, the water having been acidified to a pH such that the pH of the solution is from 6,0 to 8,5 inclusive, in the absence of a phosphate buffer. The composition so produced has good stability on storage.
Patent DK-0674902-T3 (DK)
Inventor: SCHNEIDER HEINZ
IPC: A61K31/23
Filed: 1995-02-27
Granted: 2007-07-23
Abstract: The invention provides diet supplements containing (a) omega-3 PLIFAs and (h) L-aginine and/or L-anithine or their precursors for pre-operative treatment of patients due for surgery.